Chagas disease in bone marrow transplantation: an approach to preemptive therapy
✍ Scribed by Altclas, J; Sinagra, A; Dictar, M; Luna, C; Verón, M T; De Rissio, A M; García, M M; Salgueira, C; Riarte, A
- Book ID
- 110014640
- Publisher
- Nature Publishing Group
- Year
- 2005
- Tongue
- English
- Weight
- 129 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Forty-two cytomegalovlrus (CMV)-seropositive allogeneic marrow transplant patients or recipients of CMV-seropositive marrow allografts were entered Into a surveillance program to detect and treat CMV Infection during the first 120 days posttransplant. CMV Infection was detected at a mean time of day
Cytomegalovirus infection in immunosuppressed patients is well known. It usually appears as an interstitial pneumonitis that may progress to a disseminated viral infection. The authors report on two patients who, after bone marrow transplantation, had signs and symptoms of gastric ulceration as the
PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency. Treatment with PEG-ADA almost completely corrects metabolic abnormalities, allowing the recovery of a variable